DelveInsight has launched a new report on “Prader-Willi Syndrome- Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Prader-Willi Syndrome– Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Willi Syndrome, historical and forecasted epidemiology as well as the Prader-Willi Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Prader-Willi Syndrome Market Report:
As per the Foundation for PWS Research, the disease occurs in approximately 1 out of every 15,000 births.
The Prader-Prader-Willi SyndromeAssociation (PWSA) estimates that the prevalence of PWS is approximately 1/12–15,000 people in the US. Using the more conservative estimate, this translates into a target population of about 22,000 at present, which is relatively low.
The estimates place the incidence between 1/10,000–30,000 individuals in the general population. In contrast, as per “Adult Prader-Willi Syndrome: An Update on Management by Luk Ho-Ming,” the incidence is about 1/15,000–25,000 live births. Although most of them are diagnosed during childhood, with the improvement of medical care, it is not uncommon for adult physicians to encounter PWS patients.
Key benefits of the report:
Prader-Willi Syndrome market report covers a descriptive overview and comprehensive insight of the Prader-Willi Syndrome Epidemiology and Prader-Willi Syndrome market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
The Prader-Willi Syndrome market report provides insights on the current and emerging therapies.
Prader-Willi Syndrome market report provides a global historical and forecasted market covering drug outreach in 7MM.
The Prader-Willi Syndrome market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Prader-Willi Syndrome market.
Prader-Willi Syndrome Overview
Prader-Prader-Willi Syndrome is a complex genetic condition that affects many parts of the body. This condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development in infancy. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity. Some people with Prader-Willi syndrome, particularly those with obesity, also develop type 2 diabetes (the most common form of diabetes).
Prader-Willi Syndrome Market
The dynamics of the Prader-Willi Syndrome market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Levo Therapeutics, Harmony Biosciences, Soleno Therapeutics, Lipidio Pharmaceuticals, and others during the forecasted period 2018-2030.
Learn more by requesting for sample @ Prader-Willi Syndrome Market Landscape
Prader-Willi Syndrome Pipeline Therapies and Key Companies
LV-101: Levo Therapeutics
Pitolisant: Harmony Biosciences
Diazoxide Controlled Release [DCCR]; Soleno Therapeutics
GDD3898: Lipidio Pharmaceuticals
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Prader-Willi Syndrome Patient Share (%) Overview at a Glance
5. Prader-Willi Syndrome Market Overview at a Glance
6. Prader-Willi Syndrome Disease Background and Overview
7. Prader-Willi Syndrome Epidemiology and Patient Population
8. Country-Specific Patient Population of Prader-Willi Syndrome
9. Prader-Willi Syndrome Current Treatment and Medical Practices
10. Unmet Needs
11. Prader-Willi Syndrome Emerging Therapies
12. Prader-Willi Syndrome Market Outlook
13. Country-Wise Prader-Willi Syndrome Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
18. Prader-Willi Syndrome Report Methodology
19. DelveInsight Capabilities
21. About DelveInsight
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States